Pharminent

COA Declares Early Victory in CMS Part B Payment Battle

The change of administrations in Washington, DC may undermine the future of a proposal to revise Medicare Part B drug compensation, a plan that has been widely criticized in the oncological community because of the potential reduction in profit margins it entails. http://www.onclive.com/web-exclusives/coa-declares-early-victory-in-cms-part-b-payment-battle

Filed under: Payer